SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018973
Filing Date
2019-05-14
Accepted
2019-05-14 07:47:02
Documents
62
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q goss-10q_20190331.htm 10-Q 1507700
2 EX-31.1 goss-ex311_6.htm EX-31.1 9271
3 EX-31.2 goss-ex312_7.htm EX-31.2 9267
4 EX-32.1 goss-ex321_8.htm EX-32.1 7761
5 EX-32.2 goss-ex322_9.htm EX-32.2 7767
  Complete submission text file 0001564590-19-018973.txt   5924029

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT goss-20190331.xml EX-101.INS 1205613
7 XBRL TAXONOMY EXTENSION SCHEMA goss-20190331.xsd EX-101.SCH 53182
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE goss-20190331_cal.xml EX-101.CAL 51709
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE goss-20190331_def.xml EX-101.DEF 190054
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE goss-20190331_lab.xml EX-101.LAB 421121
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE goss-20190331_pre.xml EX-101.PRE 316800
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38796 | Film No.: 19820449
SIC: 2834 Pharmaceutical Preparations